creatine has been researched along with Local Neoplasm Recurrence in 39 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirteen patients with recurrent glioblastoma were enrolled in RTOG 0625/ACRIN 6677, a prospective multicenter trial in which bevacizumab was used in combination with either temozolomide or irinotecan." | 5.17 | Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. ( Barboriak, DP; Bokstein, F; Boxerman, JL; Gilbert, MR; McKinstry, RC; Ratai, EM; Safriel, Y; Snyder, BS; Sorensen, AG; Zhang, Z, 2013) |
| "Age and choline/creatine ratio are strong independent prognostic factors in high grade gliomas." | 3.81 | Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. ( Kelekis, N; Kokakis, I; Kouloulias, V; Kouvaris, JR; Kyrgias, G; Mosa, E; Papathanasiou, M; Pissakas, G; Pistevou-Gombaki, K; Tolia, M; Tsoukalas, N; Verganelakis, D, 2015) |
| " Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens." | 3.73 | Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. ( Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL, 2005) |
| "Seven patients responded to tamoxifen therapy (three with glioblastomas multiforme; four with anaplastic astrocytomas), and nine did not (six with glioblastomas multiforme; three with anaplastic astrocytomas)." | 3.70 | Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. ( Arnold, DL; Caramanos, Z; Langleben, A; LeBlanc, R; Preul, MC; Shenouda, G; Villemure, JG, 2000) |
| "Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months." | 3.01 | Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis. ( Aseel, A; McCarthy, P; Mohammed, A, 2023) |
| "There were no significant adverse effects from FLT injected at a dose of 0." | 2.73 | NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies. ( Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM, 2008) |
| "necrosis in patients with primary brain tumors or brain metastasis." | 2.53 | Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis. ( Chen, YC; Chuang, MT; Liu, YS; Tsai, YS; Wang, CK, 2016) |
| "When MRS and MR imaging agree on prostate cancer presence, the positive predictive value is about 80-90%." | 2.44 | Proton MR spectroscopy of the prostate. ( Mueller-Lisse, UG; Scherr, MK, 2007) |
| "This supports long-term HT in advanced prostate cancer." | 1.38 | Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. ( Bonomo, P; Clementi, V; D'Agostino, GR; Di Molfetta, IV; Gui, B; Mantini, G; Mattiucci, G; Valentini, AL, 2012) |
| "The histological diagnosis was anaplastic oligodendroglioma (WHO grade III)." | 1.37 | [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma]. ( Akutsu, H; Anno, I; Isobe, T; Masumoto, T; Matsumura, A; Nakai, K; Shiigai, M; Takano, S; Yamamoto, T, 2011) |
| "Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary." | 1.30 | Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999) |
| "Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals." | 1.29 | Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995) |
| "Surgical specimens of squamous cell carcinoma arising from the upper aerodigestive tract (n = 18) and from muscle (n = 13) were examined in vitro using high-field (11 T) proton MR spectroscopy." | 1.29 | Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. ( Blackstock, W; Castillo, M; Kwock, L; Mukherji, SK; Schiro, S; Shockley, W; Soper, R; Weissler, M, 1996) |
| "A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced solid tumors." | 1.27 | Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients. ( Gall, HE; Leyva, A; O'Brien, AM; Pinedo, HM; van Groeningen, CJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.13) | 18.7374 |
| 1990's | 8 (20.51) | 18.2507 |
| 2000's | 18 (46.15) | 29.6817 |
| 2010's | 9 (23.08) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, A | 1 |
| Yuan, P | 1 |
| Huang, T | 1 |
| Li, L | 1 |
| Lyu, J | 1 |
| Aseel, A | 1 |
| McCarthy, P | 1 |
| Mohammed, A | 1 |
| Ratai, EM | 1 |
| Zhang, Z | 1 |
| Snyder, BS | 1 |
| Boxerman, JL | 1 |
| Safriel, Y | 1 |
| McKinstry, RC | 1 |
| Bokstein, F | 1 |
| Gilbert, MR | 1 |
| Sorensen, AG | 1 |
| Barboriak, DP | 1 |
| Deviers, A | 1 |
| Ken, S | 1 |
| Filleron, T | 1 |
| Rowland, B | 1 |
| Laruelo, A | 1 |
| Catalaa, I | 1 |
| Lubrano, V | 1 |
| Celsis, P | 1 |
| Berry, I | 1 |
| Mogicato, G | 1 |
| Cohen-Jonathan Moyal, E | 1 |
| Laprie, A | 2 |
| Tolia, M | 1 |
| Verganelakis, D | 1 |
| Tsoukalas, N | 1 |
| Kyrgias, G | 1 |
| Papathanasiou, M | 1 |
| Mosa, E | 1 |
| Kokakis, I | 1 |
| Kouvaris, JR | 1 |
| Pissakas, G | 1 |
| Pistevou-Gombaki, K | 1 |
| Kelekis, N | 1 |
| Kouloulias, V | 1 |
| Chuang, MT | 1 |
| Liu, YS | 1 |
| Tsai, YS | 1 |
| Chen, YC | 1 |
| Wang, CK | 1 |
| Spence, AM | 1 |
| Muzi, M | 1 |
| Link, JM | 1 |
| Hoffman, JM | 1 |
| Eary, JF | 1 |
| Krohn, KA | 1 |
| Smith, EA | 2 |
| Carlos, RC | 2 |
| Junck, LR | 1 |
| Tsien, CI | 1 |
| Elias, A | 1 |
| Sundgren, PC | 3 |
| Matsusue, E | 1 |
| Fink, JR | 1 |
| Rockhill, JK | 1 |
| Ogawa, T | 1 |
| Maravilla, KR | 1 |
| Goenka, AH | 1 |
| Kumar, A | 1 |
| Sharma, R | 1 |
| Kirilova, A | 1 |
| Damyanovich, A | 1 |
| Crook, J | 1 |
| Jezioranski, J | 1 |
| Wallace, K | 1 |
| Pintilie, M | 1 |
| Isobe, T | 1 |
| Akutsu, H | 1 |
| Yamamoto, T | 1 |
| Shiigai, M | 1 |
| Masumoto, T | 1 |
| Nakai, K | 1 |
| Takano, S | 1 |
| Anno, I | 1 |
| Matsumura, A | 1 |
| Elias, AE | 1 |
| Frechtling, D | 1 |
| George, B | 1 |
| Maly, P | 2 |
| Valentini, AL | 1 |
| Gui, B | 1 |
| D'Agostino, GR | 1 |
| Mattiucci, G | 1 |
| Clementi, V | 1 |
| Di Molfetta, IV | 1 |
| Bonomo, P | 1 |
| Mantini, G | 1 |
| Rock, JP | 1 |
| Hearshen, D | 1 |
| Scarpace, L | 1 |
| Croteau, D | 1 |
| Gutierrez, J | 1 |
| Fisher, JL | 1 |
| Rosenblum, ML | 1 |
| Mikkelsen, T | 1 |
| Mueller-Lisse, UG | 2 |
| Scherr, M | 1 |
| BRANDSTETTER, F | 1 |
| GITSCH, E | 1 |
| SCHULLER, E | 1 |
| Lichy, MP | 1 |
| Bachert, P | 1 |
| Henze, M | 1 |
| Lichy, CM | 1 |
| Debus, J | 1 |
| Schlemmer, HP | 1 |
| Ando, K | 1 |
| Ishikura, R | 1 |
| Nagami, Y | 1 |
| Morikawa, T | 1 |
| Takada, Y | 1 |
| Ikeda, J | 1 |
| Nakao, N | 1 |
| Matsumoto, T | 1 |
| Arita, N | 1 |
| Chan, AA | 1 |
| Lau, A | 1 |
| Pirzkall, A | 2 |
| Chang, SM | 1 |
| Verhey, LJ | 1 |
| Larson, D | 2 |
| McDermott, MW | 1 |
| Dillon, WP | 3 |
| Nelson, SJ | 3 |
| Plotkin, M | 1 |
| Eisenacher, J | 1 |
| Bruhn, H | 1 |
| Wurm, R | 1 |
| Michel, R | 1 |
| Stockhammer, F | 1 |
| Feussner, A | 1 |
| Dudeck, O | 1 |
| Wust, P | 1 |
| Felix, R | 1 |
| Amthauer, H | 1 |
| Raizer, JJ | 1 |
| Koutcher, JA | 1 |
| Abrey, LE | 1 |
| Panageas, KS | 1 |
| DeAngelis, LM | 1 |
| Lis, E | 1 |
| Xu, S | 1 |
| Zakian, KL | 1 |
| Haas-Kogan, DA | 1 |
| Cha, S | 1 |
| Banerjee, A | 1 |
| Le, TP | 1 |
| Lu, Y | 1 |
| Nelson, S | 1 |
| McKnight, TR | 1 |
| Weybright, P | 1 |
| Hassan, DG | 1 |
| Nan, B | 1 |
| Rohrer, S | 1 |
| Junck, L | 1 |
| Zeng, QS | 1 |
| Li, CF | 1 |
| Zhang, K | 1 |
| Liu, H | 2 |
| Kang, XS | 1 |
| Zhen, JH | 1 |
| Scherr, MK | 1 |
| Sijens, PE | 1 |
| Vecht, CJ | 1 |
| Levendag, PC | 1 |
| van Dijk, P | 1 |
| Oudkerk, M | 1 |
| Mukherji, SK | 1 |
| Schiro, S | 1 |
| Castillo, M | 1 |
| Kwock, L | 1 |
| Soper, R | 1 |
| Blackstock, W | 1 |
| Shockley, W | 1 |
| Weissler, M | 1 |
| Tedeschi, G | 1 |
| Lundbom, N | 1 |
| Raman, R | 1 |
| Bonavita, S | 1 |
| Duyn, JH | 1 |
| Alger, JR | 2 |
| Di Chiro, G | 1 |
| Wald, LL | 1 |
| Day, MR | 1 |
| Noworolski, SE | 1 |
| Henry, RG | 1 |
| Huhn, SL | 1 |
| Chang, S | 2 |
| Prados, MD | 2 |
| Sneed, PK | 2 |
| Larson, DA | 1 |
| Wara, WM | 1 |
| McDermott, M | 2 |
| Gutin, PH | 1 |
| Vigneron, DB | 2 |
| Kinoshita, K | 1 |
| Tada, E | 1 |
| Matsumoto, K | 1 |
| Asari, S | 1 |
| Ohmoto, T | 1 |
| Itoh, T | 1 |
| Burtscher, IM | 1 |
| Ståhlberg, F | 1 |
| Holtås, S | 1 |
| Lazareff, JA | 1 |
| Bockhorst, KH | 1 |
| Curran, J | 1 |
| Olmstead, C | 1 |
| Shino, A | 1 |
| Nakasu, S | 1 |
| Matsuda, M | 1 |
| Handa, J | 1 |
| Morikawa, S | 1 |
| Inubushi, T | 1 |
| Preul, MC | 1 |
| Caramanos, Z | 1 |
| Villemure, JG | 1 |
| Shenouda, G | 1 |
| LeBlanc, R | 1 |
| Langleben, A | 1 |
| Arnold, DL | 1 |
| Graves, EE | 1 |
| Chin, C | 1 |
| Verhey, L | 1 |
| Lamborn, K | 1 |
| Ricci, PE | 1 |
| Pitt, A | 1 |
| Keller, PJ | 1 |
| Coons, SW | 1 |
| Heiserman, JE | 1 |
| Hall, WA | 1 |
| Martin, AJ | 1 |
| Truwit, CL | 1 |
| van Groeningen, CJ | 1 |
| Leyva, A | 1 |
| O'Brien, AM | 1 |
| Gall, HE | 1 |
| Pinedo, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors[NCT00276770] | 12 participants (Actual) | Interventional | 2006-02-28 | Completed | |||
| Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206] | 12 participants (Anticipated) | Observational | 2020-12-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for creatine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Cr | 2023 |
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
Topics: Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Hum | 2016 |
[1H magnetic resonance spectroscopy of the prostate].
Topics: Biopsy; Choline; Citrates; Creatine; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Magnetic | 2003 |
Proton MR spectroscopy of the prostate.
Topics: Biopsy; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Imaging, Three-Dimensional; | 2007 |
4 trials available for creatine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Be | 2013 |
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea | 2014 |
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Si | 2008 |
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fema | 2007 |
31 other studies available for creatine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Topics: Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; | 2022 |
Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas.
Topics: Adult; Age Factors; Aged; Choline; Creatine; Disease-Free Survival; Female; Glioma; Humans; Magnetic | 2015 |
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast | 2009 |
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Cr | 2010 |
MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast | 2009 |
3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
Topics: Brachytherapy; Choline; Citric Acid; Creatine; Humans; Iodine Radioisotopes; Magnetic Resonance Imag | 2011 |
[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
Topics: Adult; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; F | 2011 |
MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Diagn | 2011 |
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Choline; Combined Moda | 2012 |
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip | 2002 |
[Effects of vitamin E on kreatinin metabolism in recurrent female genital carcinoma].
Topics: Carcinoma; Creatine; Female; Genitalia; Genitalia, Female; Humans; Neoplasm Recurrence, Local; Neopl | 1955 |
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms; | 2004 |
[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Female; Glioma | 2004 |
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor | 2004 |
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Female; Glioblastoma; Huma | 2004 |
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous Syst | 2005 |
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression | 2005 |
Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast Media; | 2005 |
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four | 1995 |
Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics.
Topics: Carcinoma, Squamous Cell; Choline; Confidence Intervals; Creatine; Esophageal Neoplasms; Esophagus; | 1996 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas | 1997 |
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Pro | 1997 |
Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
Topics: Adult; Animals; Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Cranial Irradiation; | 1997 |
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo | 1997 |
Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.
Topics: Adolescent; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Child; Child, Prescho | 1998 |
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra | 1999 |
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Astro | 2000 |
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Choline; Creatine; Female; Glioblastoma; Humans; Lactic Aci | 2000 |
Effect of voxel position on single-voxel MR spectroscopy findings.
Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio | 2000 |
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop | 2001 |
Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
Topics: Adult; Aged; Azacitidine; Creatine; Decitabine; Dose-Response Relationship, Drug; Drug Administratio | 1986 |